Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas

Bone sarcomas are a heterogeneous group of rare tumors with a predominance in the young population. Few options of systemic treatment are available once they become unresectable and resistant to conventional chemotherapy. A better knowledge of the key role that tyrosine kinase receptors (VEGFR, RET,...

Descripción completa

Detalles Bibliográficos
Autores principales: Albarrán, Víctor, Villamayor, María Luisa, Chamorro, Jesús, Rosero, Diana Isabel, Pozas, Javier, San Román, María, Calvo, Juan Carlos, Pérez de Aguado, Patricia, Moreno, Jaime, Guerrero, Patricia, González, Carlos, García de Quevedo, Coral, Álvarez-Ballesteros, Pablo, Vaz, María Ángeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697271/
https://www.ncbi.nlm.nih.gov/pubmed/36430263
http://dx.doi.org/10.3390/ijms232213784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697271/
https://www.ncbi.nlm.nih.gov/pubmed/36430263
http://dx.doi.org/10.3390/ijms232213784

Ejemplares similares